Skip to main content
Publications
Rebordosa C , Plana E , Rubino A, Aguado J , Martinez D , Lei A, Daoud S, Saigi-Morgui N , Perez-Gutthann S , Rivero-Ferrer E . Risk assessment of acute myocardial infarction and stroke associated with long-acting muscarinic antagonists, alone or in combination, versus long-acting beta2-agonists . Int J Chron Obstruct Pulmon Dis. 2022 Aug 2;17:1715-33. doi: 10.2147/COPD.S363997
Saigi-Morgui N , Rebordosa C , Plana E , Rubino A, Aguado J , Martinez D , Lei A, Daoud SZ, McMahon P, Perez-Gutthann S , Rivero-Ferrer E . Acute myocardial infarction, stroke, and MACE in COPD patients treated with aclidinium and other inhaled bronchodilators . Poster presented at the 2022 ICPE Conference; August 2022. Copenhagen, Denmark.
Rivero-Ferrer E , Olesen M, Plana E , Aguado J , Saigi-Morgui N , Rubino A, Daoud SZ, Lei A, Perez-Gutthann S , Schink S, Kristiansen NS, Hallas J, Pottegard A, Rebordosa C . Characteristics of new users of aclidinium bromide, aclidinium/formoterol, and other COPD medications in the United Kingdom, Denmark, and Germany . Clin Drug Invest. 2022 Apr;42(4):319-31. doi: 10.1007/s40261-022-01120-2
Rebordosa C , Rubino A, Witzleb AJ, Olesen M, Plana E , Aguado J , Saigi N , Daoud SZ, Lei A, Perez-Gutthann S , Schink T, Kristiansen NS, Pottegard A, Rivero-Ferrer E . Characteristics of new users of aclidinium, aclidinium/formoterol, and other COPD medications in three European countries . Poster presented at the 2020 Virtual ERS International Congress; October 2020. [abstract] Eur Respir J. 2020 Oct 28; 56(Suppl 64):2071. doi: 10.1183/13993003.congress-2020.2072
Rivero-Ferrer E , Witzleb AJ, Olesen M, Plana E , Aguado J , Saigi-Morgui N , Rubino A, Daoud SZ, Lei A, Perez-Gutthann S , Schink T, Kristiansen NS, Pottegard A, Rebordosa C . Are aclidinium and aclidinium/formoterol used according to their approved indication in Europe? Results of a multicountry drug utilization postauthorization safety study . Poster presented at the 2020 36th ICPE International Virtual Conference on Pharmacoepidemiology & Therapeutic Risk Management; September 16, 2020.
Plana E , Rivero-Ferrer E , Aguado J , Saigi-Morgui N , Nuevo J, Daoud SZ, Lei A, Perez-Gutthann S , Rebordosa C . Hospitalization for heart failure among patients using aclidinium bromide and other COPD medications: a post-authorisation safety study in the CPRD . Poster presented at the 35th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 28, 2019. Philadelphia, PA. [abstract] Pharmacoepidemiol Drug Saf. 2019 Aug 20; 28(S2):1153. doi: 10.1002/pds.4864
Saigi N , Rebordosa C , Bui C , Aguado J , Plana E , Nuevo J, Daoud SZ, Lei A, Perez-Gutthann S , Rivero-Ferrer E . A validation exercise: identifying hospitalizations for heart failure among patients with COPD in the CPRD . Poster presented at the 35th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 26, 2019. Philadelphia, PA. [abstract] Pharmacoepidemiol Drug Saf. 2019 Aug 20; 28(S2):334. doi: 10.1002/pds.4864
Cainzos-Achirica M, Rebordosa C , Vela E, Cleries M, Matsushita K, Plana E , Rivero-Ferrer E , Enjuanes C, Jimenez-Marrero S, Garcia-Rodriguez LA, Comin-Colet J, Perez-Gutthann S . Challenges of evaluating chronic heart failure and acute heart failure events in research studies using large health care databases . Am Heart J. 2018 Aug;202:76-83. doi: 10.1016/j.ahj.2018.05.005
Didden E-M, Andrews EB, Hellwig K, Hernandez-Diaz S, Magyari M, Margulis AV , Rivero-Ferrer E , Bader-Weder S, Wormser D. A novel approach for active surveillance of pregnancy safety in multiple sclerosis . Poster presented at the 34th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 25, 2018. Prague, Czech Republic. [abstract] Pharmacoepidemiol Drug Saf. 2018 Aug; 27(S2):268. doi: 10.1002/pds.4629
Margulis A , Andrews E, Hernandez-Diaz S, Magyari M, Rivero-Ferrer E , Bader-Weder S, Evershed J, Garas M, Wang Q, Wormser D. Design of a multi-source post-marketing study to evaluate pregnancy and infant outcomes in women with multiple sclerosis who were exposed to ocrelizumab during, or within 6 months before, pregnancy . Poster presented at the 2018 American Academy of Neurology Annual Meeting; April 25, 2018. Los Angeles, CA.
Krueger WS, Anthony MS , Saltus CW , Margulis AV , Rivero-Ferrer E , Monz B, Wormser D, Andrews E. Existing databases useful for pregnancy exposure and fetal outcomes research, case study in multiple sclerosis (MS) . Poster presented at the 33rd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 29, 2017. Montreal, Canada. [abstract] Pharmacoepidemiol Drug Saf. 2017 Aug; 26(Suppl 2):403. doi: 10.1002/pds
Anthony M , Calingaert B , McQuay LJ, Andrews E, McGrath L, Rothman KJ , Rivero-Ferrer E . Suicide, suicidal behavior, and mortality rates in patients with psoriasis in England . Presented at the 33rd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 30, 2017. Montreal, Canada. [abstract] Pharmacoepidemiol Drug Saf. 2017 Aug; 26(Suppl 2):475. doi: 10.1002/pds
Farrar J, Rivero E , Silman A, Hochberg M, Pandhi S, Banerjee S, Kahler K, Hunter S, Candrilli S , Castellsague J. Usage patterns of diclofenac and other selected systemic NSAIDs in the United States: results from a retrospective cohort of new users . Poster presented at the IASP World Congress on Pain 2016; September 27, 2016. Yokohama, Japan.
Margulis AV , Varas-Lorenzo C, Bui CL , McQuay LJ, Ziemiecki R , Reynolds M , Rebordosa C , Pladevall-Vila M , Fortuny J , Rivero-Ferrer E , Plana E , Atsma WJ, Appenteng K, Franks B, de Vogel S, D'Silva M, Perez-Gutthann S , Arana A . Validation of cardiovascular events and covariates in CPRD GOLD using questionnaires to general practitioners (GPS) . Presented at the 32nd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 27, 2016. Dublin, Ireland. [abstract] Pharmacoepidemiol Drug Saf. 2016 Aug; 25(Suppl 3):255-6.
Sabate M, Pacheco JF, Ballarín E , Ferrer P, Petri H, Hasford J, Schoonen MW, Rottenkolber M, Fortuny J , Laporte JR, Ibanez L. A compilation of research working groups on drug utilisation across Europe . BMC Res Notes. 2014;7:143.